Seed Round

ArcaScience is an AI healthtech startup based in Paris that transforms drug development by turning unstructured biomedical data into crucial benefit-risk insights. This innovation helps pharmaceutical companies and regulators evaluate drug candidates more effectively. The funding will enable the company to expand its AI-powered platform for drug benefit-risk evaluation, enhancing the efficiency and accuracy of the drug development process. The company aims to launch patient solutions and expand its operations into the US and UK markets. This funding round marks ArcaScience's first institutional funding, following a previous pre-seed raise of €1.3 million with Plug & Play Ventures and angel investors. The round was led by The Moon Venture, with participation from various angel investors, including notable figures in the healthtech sector. The funds will be utilized to enhance their technology, hire key personnel, and accelerate market entry strategies.